folic acid has been researched along with Epithelial Ovarian Cancer in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Kinnel, B; McFadden, M; Singh, R; Singh, SK; Varambally, S | 1 |
| Banerjee, S; Banerji, U; Cojocaru, E; Scaranti, M | 1 |
| Wang, K; Yang, J; Zhang, Q | 1 |
| Azaïs, H; Collinet, P; Colombeau, L; Delhem, N; Frochot, C; Grabarz, A; Khodja Bach, S; Mordon, S | 1 |
| Bagnoli, M; Mezzanzanica, D; Napoli, A; Rizzo, A; Roggiani, F; Tomassetti, A | 1 |
| Dowdy, SC; Low, PS; Randall, LM; Tanyi, JL; Wenham, RM | 1 |
| Beesley, J; Crandon, AJ; deFazio, A; Dixon, SC; Gard, GB; Ibiebele, TI; Nagle, CM; Protani, MM; Rome, RM; Webb, PM | 1 |
| Coleman, RL; Graybill, WS | 1 |
| Matsumoto, K; Onda, T; Yaegashi, N | 1 |
| George, AJ; Ghaem-Maghami, S; Hedrick, JL; Maher, J; Parente-Pereira, AC; Teo, PY; Whilding, LM; Yang, C; Yang, YY | 1 |
| Anderson, KE; Clendenen, TV; Eliassen, AH; Freudenheim, JL; Genkinger, JM; Håkansson, N; Koushik, A; Marshall, JR; McCullough, ML; Miller, AB; Robien, K; Rohan, TE; Schairer, C; Schouten, LJ; Smith-Warner, SA; Tworoger, SS; van den Brandt, P; Wang, M; Wang, Y; Wolk, A; Zeleniuch-Jacquotte, A | 1 |
| Azaïs, H; Betrouni, N; Collinet, P; Frochot, C; Kerdraon, O; Mordon, S; Schmitt, C; Stallivieri, A; Tardivel, M | 1 |
| Azaïs, H; Betrouni, N; Bonner, C; Collinet, P; Frochot, C; Jetpisbayeva, G; Kerdraon, O; Mordon, S; Queniat, G; Tardivel, M | 1 |
| Corbin, IR; Ding, L; Jurisicova, A; Ng, KK; Zheng, G | 1 |
4 review(s) available for folic acid and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Exploiting the folate receptor α in oncology.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Female; Fluorescent Dyes; Folate Receptor 1; Folic Acid; Folic Acid Antagonists; Humans; Immunoconjugates; Immunologic Factors; Immunotherapy, Adoptive; Lung Neoplasms; Maytansine; Mesothelioma; Molecular Imaging; Molecular Targeted Therapy; Neoplasms; Optical Imaging; Ovarian Neoplasms; Radionuclide Imaging; Theranostic Nanomedicine; Tubulin Modulators | 2020 |
The effect of folate intake on ovarian cancer risk: A meta-analysis of observational studies.
Topics: Carcinoma, Ovarian Epithelial; Dietary Supplements; Female; Folic Acid; Humans; Observational Studies as Topic; Ovarian Neoplasms; Risk Factors | 2021 |
One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer.
Topics: Carbon; Carcinoma, Ovarian Epithelial; Choline; Female; Folic Acid; Humans; Models, Biological; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms | 2018 |
Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Carcinoma, Ovarian Epithelial; Deoxycytidine; Doxorubicin; Everolimus; Female; Folic Acid; Gemcitabine; Humans; Indazoles; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Nivolumab; Ovarian Neoplasms; Paclitaxel; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Glycols; Pyrimidines; Quinazolines; Recombinant Fusion Proteins; Sirolimus; Sulfonamides; Topotecan; TOR Serine-Threonine Kinases; Vinca Alkaloids | 2015 |
1 trial(s) available for folic acid and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Coloring Agents; Cytoreduction Surgical Procedures; Female; Folate Receptor 1; Folic Acid; Humans; Indocyanine Green; Middle Aged; Ovarian Neoplasms; Prospective Studies; Spectroscopy, Near-Infrared; Surgery, Computer-Assisted | 2019 |
9 other study(ies) available for folic acid and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Folic Acid; Humans; Nanoparticles; Neoplasm Proteins; Ovarian Neoplasms; Paclitaxel; Pharmaceutical Preparations | 2023 |
[Specific folic-acid targeted photosensitizer. The first step toward intraperitoneal photodynamic therapy for epithelial ovarian cancer].
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Combined Modality Therapy; Cytoreduction Surgical Procedures; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Mice; Necrosis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Inbred F344 | 2017 |
Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival.
Topics: Aged; Alcohol Drinking; Australia; Carcinoma, Ovarian Epithelial; Case-Control Studies; Cohort Studies; Diet; Fallopian Tube Neoplasms; Female; Folic Acid; Humans; Micronutrients; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Polymorphism, Single Nucleotide; Smoking; Surveys and Questionnaires | 2014 |
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; Folic Acid; Humans; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Treatment Outcome; Vinca Alkaloids | 2014 |
Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing.
Topics: B7-H1 Antigen; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Down-Regulation; Female; Folic Acid; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Immunotherapy; Lysosomal-Associated Membrane Protein 1; Nanoparticles; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Particle Size; Polyethylene Glycols; Polyethyleneimine; Polymers; RNA, Small Interfering; T-Lymphocytes | 2015 |
Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies.
Topics: Adult; Ascorbic Acid; Carcinoma, Ovarian Epithelial; Cohort Studies; Dietary Supplements; Europe; Female; Folic Acid; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; North America; Ovarian Neoplasms; Prospective Studies; Risk; Vitamin A; Vitamin E; Vitamins | 2015 |
Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Female; Folate Receptor 1; Folic Acid; Injections, Intraperitoneal; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Rats; Rats, Inbred F344; Treatment Outcome | 2016 |
Fischer 344 Rat: A Preclinical Model for Epithelial Ovarian Cancer Folate-Targeted Therapy.
Topics: Animals; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Proliferation; Disease Models, Animal; Female; Fluorescent Antibody Technique; Folate Receptor 1; Folic Acid; Humans; Immunoenzyme Techniques; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Photosensitizing Agents; Rats; Rats, Inbred F344; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.
Topics: Animals; Carcinoma, Ovarian Epithelial; Drug Delivery Systems; Female; Folate Receptor 1; Folic Acid; Lipoproteins, HDL; Mice; Mice, Inbred C57BL; Nanoparticles; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary | 2013 |